T Cells Clinical Trials

2 recruiting

T Cells Trials at a Glance

9 actively recruiting trials for t cells are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Nanning, Pessac, and Clermont-Ferrand. Lead sponsors running t cells studies include TCRx Therapeutics Co.Ltd, Medical College of Wisconsin, and M.D. Anderson Cancer Center.

Browse t cells trials by phase

Treatments under study

About T Cells Clinical Trials

Looking for clinical trials for T Cells? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new T Cells trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about T Cells clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1Phase 2

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

Peripheral T Cells Lymphoma (PTCL)
The Lymphoma Academic Research Organisation49 enrolled20 locationsNCT07018752
Recruiting
Not Applicable

Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?

ExerciseTumor MicroenvironmentT Cells+1 more
University of Surrey50 enrolled1 locationNCT07375420
Recruiting
Phase 2

Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL

Peripheral T Cells Lymphoma (PTCL)
The First Affiliated Hospital of Soochow University26 enrolled1 locationNCT07372352
Recruiting

Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma

Multiple MyelomaMonocytesCART Cells
Centre Hospitalier Universitaire, Amiens25 enrolled1 locationNCT07180992
Recruiting
Phase 2

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

T Cells
M.D. Anderson Cancer Center40 enrolled1 locationNCT05411718
Recruiting
Phase 1Phase 2

Polyspecific Antibodies in Lymphoproliferative T-cell Disorders

Peripheral T Cells Lymphoma (PTCL)
Xenothera SAS54 enrolled8 locationsNCT06495723
Recruiting
Not Applicable

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

LeukemiaAcute Myeloid Leukemia in RemissionLymphoblastic Lymphoma+10 more
Medical College of Wisconsin40 enrolled1 locationNCT05794880
Recruiting
Early Phase 1

KSH01-TCRT Solid Tumors

Refractory Solid TumorsRelapsed Solid TumorsTCR-T Cells
TCRx Therapeutics Co.Ltd50 enrolled1 locationNCT05539833
Recruiting
Early Phase 1

KSX01-TCRT Injection Project in Solid Tumors

Refractory Solid TumorsRelapsed Solid TumorsTCR-T Cells
TCRx Therapeutics Co.Ltd50 enrolled1 locationNCT05811975